Gaize, Inc., on the 17th of November, 2022, announced the completion of the world’s most extensive clinical research investigating cannabis impairment. Gaize’s portable, non-invasive testing apparatus was employed in the 350-person study to assess pupillary reflex and eye movement response alterations.
